Background : Advanced novel therapies and antiretroviral medications for the treatment of human immunodeficiency virus (HIV) infection have led to the improved management and survival of the infected patients. However, I [i]t manifestations in late-stage diseases such as cardiac deformities, which are the major cause of fatality in HIV-infected patients. Hence the current study was undertaken to derive the association of cardiac dysfunctions in HIV-infected patients using electrocardiograph (ECG)and echocardiography (ECHO).
Methodology : The study included a total of 100 consecutive patients with HIV infection and was performed during January–December 2016 in the Department of General Medicine. Prior to the commencement of the study, ethical clearance was obtained from the Institutional Ethical Committee. Patients underwent complete blood count, ECG, and ECHO. Data were analyzed using Microsoft Excel spreadsheet and R-3.4.1 software.
Results : Majority of the patients were males (79) and 40–49 years was the most common age group. The duration of HIV infection in most of the patients (73) was 1–10 years. Among the study population, 79 patients received antiretroviral drugs. Chi-square test was used to find the association of clinical symptoms and cardiac abnormalities with CD4 count. Cardiac manifestations were observed in 62% patients; sinus tachycardia (29%) was found to be the most common cardiac manifestation on ECG. Diastolic and systolic dysfunctions were observed in 35 patients and 49 patients, respectively.
Conclusion : Patients with HIV infection are at a higher risk of developing cardiac dysfunctions. Early identification through ECG and ECHO-revealed abnormalities might assist in cardiac-targeted interventions, which can significantly reduce the fatal outcomes in HIV-infected patients.



Fajardo-Ortiz D, Lopez-Cervantes M, Duran L, Dumontier M, Lara M, Ochoa H, et al. The emergence and evolution of the research fronts in HIV/AIDS research. PLoS One. 2017;12:e0178293.

Barbaro G. Cardiovascular manifestations of HIV infection. J R Soc Med. 2001;94:384-90.

Kaul S, Fishbein MC, Siegel RJ. Cardiac manifestations of acquired immune deficiency syndrome: a 1991 update. Am Heart J. 1991;122:535-44.

Glesby MJ. Cardiovascular Complications of HIV Infection. Top Antivir Med. 2017;24:127-31.

Reinsch N, Kahlert P, Esser S, Sundermeyer A, Neuhaus K, Brockmeyer N, et al. Echocardiographic findings and abnormalities in HIV-infected patients: results from a large, prospective, multicenter HIV-heart study. Am J Cardiovasc Dis. 2011;1:176-84.

Steeds RP. Echocardiography: frontier imaging in cardiology. Br J Radiol. 2011;84 Spec No 3:S237-45.

Becker DE. Fundamentals of electrocardiography interpretation. Anesth Prog. 2006;53:53-63; quiz 4.

Maleki M, Esmaeilzadeh M. The evolutionary development of echocardiography. Iran J Med Sci. 2012;37:222-32.

Steeds RP. Echocardiography: frontier imaging in cardiology. Br J Radiol. 2011;84 Spec No 3:S237-45.

Becker DE. Fundamentals of electrocardiography interpretation. Anesth Prog. 2006;53:53-63; quiz 4.

Estes EH, Zhang ZM, Li Y, Tereschenko LG, Soliman EZ. The Romhilt-Estes left ventricular hypertrophy score and its components predict all-cause mortality in the general population. Am Heart J. 2015;170:104-9.

Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol. 1987;18:619-24.

Deuffic-Burban S, Losina E, Wang B, Gabillard D, Messou E, Divi N, et al. Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Cote d'Ivoire: impact of alternative methods of CD4 count modelling. Eur J Epidemiol. 2007;22:737-44.

Naif HM. Pathogenesis of HIV Infection. Infect Dis Rep. 2013;5:e6.

Antwal M, Gurjar R, Chidrawar S, Pawar J, Gaikwad S, Panchal N, et al. Clinical profile of HIV infected patients attending a HIV referral clinic in Pune, India. Indian J Med Res. 2014;140:271-7.

Wal N, Venkatesh V, Agarwal GG, Tripathi AK. Profile of CD4 counts and symptoms in HIV positive patients on and not on antiretroviral therapy. J Commun Dis. 2011;43:51-6.

Demir S, Tufenk M, Karakaya Z, Akilli R, Kanadas M. The treatment of heart failure-related symptoms with ivabradine in a case with peripartum cardiomyopathy. Int Cardiovasc Res J. 2013;7:33-6.

Lipshultz SE, Chanock S, Sanders SP, Colan SD, Perez-Atayde A, McIntosh K. Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol. 1989;63:1489-97.

Lubega S, Zirembuzi GW, Lwabi P. Heart disease among children with HIV/AIDS attending the paediatric infectious disease clinic at Mulago Hospital. Afr Health Sci. 2005;5:219-26.

Fontes-Carvalho R, Mancio J, Marcos A, Sampaio F, Mota M, Rocha Goncalves F, et al. HIV patients have impaired diastolic function that is not aggravated by anti-retroviral treatment. Cardiovasc Drugs Ther. 2015;29:31-9.

Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, et al. Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2010;11:156-62.

Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, et al. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 2010;3:132-9.

Almodovar S, Hsue PY, Morelli J, Huang L, Flores SC, Lung HIVS. Pathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef. Proc Am Thorac Soc. 2011;8:308-12.

Barbaro G. Pathogenesis of HIV-associated heart disease. AIDS. 2003;17 Suppl 1:S12-20.

Malek J, Rogers R, Kufera J, Hirshon JM. Venous thromboembolic disease in the HIV-infected patient. Am J Emerg Med. 2011;29:278-82.

Quezada M, Martin-Carbonero L, Soriano V, Vispo E, Valencia E, Moreno V, et al. Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up. AIDS. 2012;26:1387-92.

Lind A, Reinsch N, Neuhaus K, Esser S, Brockmeyer NH, Potthoff A, et al. Pericardial effusion of HIV-infected patients ? Results of a prospective multicenter cohort study in the era of antiretroviral therapy. Eur J Med Res. 2011;16:480-3.

Reinsch N, Esser S, Gelbrich G, Brockmeyer N, Potthoff A, Schadendorf D, et al. Valvular manifestations of human immunodeficiency virus infection--results from the prospective, multicenter HIV-HEART study. J Cardiovasc Med (Hagerstown). 2013;14:733-9.

El Hattaoui M, Charei N, Boumzebra D, Aajly L, Fadouach S. [Prevalence of cardiomyopathy in HIV infection: prospective study on 158 HIV patients]. Med Mal Infect. 2008;38:387-91.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Université Mohammed VI des Sciences de la Santé